Resources
Healthcare IT Today January 15, 2024 Read the full article >> Joseph Zabinski, Ph.D., Managing Director, AI & Personalized Medicine at OM1 The Anti-Prediction of AI in 2024: The healthcare industry likes to compare artificial intelligence (AI) to a standard of perfection – we want it to get the answer ‘right’ every time, and sometimes, we’ll[…]
HealthEconomics.com November 15, 2023 Listen to the full podcast >> The hype around AI is finally translating into real-world value, and we are seeing broader adoption of real-world data in Dermatology. This episode of tHEORetically Speaking features Dr. Stefan Weiss, Managing Director of Dermatology and Dr. Joseph Zabinski, Managing Director of AI and Personalized Medicine[…]
Dermatology Times October 3, 2023 Read the full article >> OM1, a real-world data and AI technology company, recently announced the continued expansion of its Dermatology Network to now include hidradenitis suppurativa (HS), adding approximately 26,000 new patient records to its database. The addition of the HS database will help find innovative solutions and improve health outcomes[…]
Dermatology Times October 3, 2023 Read the full article >> Artificial intelligence (AI) has been a buzzword in health care for some time, but do clinicians, especially in dermatology, view it as friend or foe? Applications and use of AI in dermatology are comparatively new and have focused primarily on the relatively narrow application of[…]
Practical Dermatology September 22, 2023 Read the full article >> OM1 is expanding its Dermatology Network to include almost 26,000 hidradenitis suppurativa (HS) patient records. “HS patients benefit when all available information on their journey can be surfaced and used to improve care and decision-making,” Joseph Zabinski tells DermWire. He is the Managing Director of AI and Personalized Medicine at OM1. “Much of this[…]
